Neutralizing antibodies after three doses of the BNT162b2 vaccine, breakthrough infection, and symptoms during the Omicron-predominant wave

OBJECTIVES: To investigate the role of immunogenicity after the third vaccine dose against Omicron infection and COVID-19-compatible symptoms of infection. METHODS: First, we examined vaccine effectiveness (VE) of the third dose against the second dose during the Omicron wave among the staff at a te...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamamoto, Shohei, Matsuda, Kouki, Maeda, Kenji, Horii, Kumi, Okudera, Kaori, Oshiro, Yusuke, Inamura, Natsumi, Takeuchi, Junko S., Konishi, Maki, Ozeki, Mitsuru, Mizoue, Tetsuya, Sugiyama, Haruhito, Aoyanagi, Nobuyoshi, Mitsuya, Hiroaki, Sugiura, Wataru, Ohmagari, Norio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9867771/
https://www.ncbi.nlm.nih.gov/pubmed/36693493
http://dx.doi.org/10.1016/j.ijid.2023.01.023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9867771/
https://www.ncbi.nlm.nih.gov/pubmed/36693493
http://dx.doi.org/10.1016/j.ijid.2023.01.023

Ejemplares similares